(Reuters) -Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, for reducing the risk of kidney ...

Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, for reducing the risk of kidney failure and ...

GLP-1 receptor agonist medications like Ozempic have been talked about so much that its side effects (like nausea and ...

Women using Ozempic and similar drugs are reporting changes in the vulva area, termed 'Ozempic vulva,' including sagging, ...

Diabetic medicine Ozempic now approved by Health Canada to reduce the risk of further kidney decline among patients with Type ...

The viral weight-loss GLP-1 injection is now in the dock with $2 billion lawsuits as patients allege stomach paralysis, ...

TORONTO — Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes ...

Ozempic and other GLP-1 drugs have become extremely popular for their ability to manage Type 2 diabetes symptoms and spur ...

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...

The legal battle over Ozempic is getting bigger by the day. Multiple lawsuits have been filed against the ...